Augmedix (OTCMKTS:AUGX – Get Rating) and Grab (NASDAQ:GRAB – Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk. Insider & Institutional Ownership 59.0% of Augmedix shares are owned by institutional […]
Augmedix (OTCMKTS: AUGX) has recently received a number of price target changes and ratings updates: 5/31/2022 – Augmedix was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Augmedix Inc. is a provider of remote medical documentation and live clinical support. Augmedix Inc. is based in […]
Augmedix (OTCMKTS:AUGX – Get Rating) is one of 227 publicly-traded companies in the “Business services, not elsewhere classified” industry, but how does it compare to its peers? We will compare Augmedix to similar businesses based on the strength of its valuation, analyst recommendations, risk, dividends, earnings, profitability and institutional ownership. Insider and Institutional Ownership 59.0% […]
Augmedix (OTCMKTS:AUGX – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Monday, Zacks.com reports. The firm currently has a $2.25 price target on the stock. Zacks Investment Research‘s target price points to a potential upside of 6.64% from the […]
Augmedix (OTCMKTS:AUGX – Get Rating) is one of 226 publicly-traded companies in the “Business services, not elsewhere classified” industry, but how does it compare to its peers? We will compare Augmedix to similar businesses based on the strength of its dividends, earnings, profitability, valuation, institutional ownership, analyst recommendations and risk. Institutional and Insider Ownership 59.0% […]